全文获取类型
收费全文 | 233143篇 |
免费 | 20272篇 |
国内免费 | 8293篇 |
专业分类
耳鼻咽喉 | 1332篇 |
儿科学 | 5135篇 |
妇产科学 | 2946篇 |
基础医学 | 40120篇 |
口腔科学 | 4477篇 |
临床医学 | 16203篇 |
内科学 | 37328篇 |
皮肤病学 | 4035篇 |
神经病学 | 17422篇 |
特种医学 | 4656篇 |
外国民族医学 | 63篇 |
外科学 | 17706篇 |
综合类 | 30163篇 |
现状与发展 | 32篇 |
预防医学 | 12562篇 |
眼科学 | 2611篇 |
药学 | 31382篇 |
24篇 | |
中国医学 | 9154篇 |
肿瘤学 | 24357篇 |
出版年
2024年 | 566篇 |
2023年 | 3364篇 |
2022年 | 6984篇 |
2021年 | 8879篇 |
2020年 | 7301篇 |
2019年 | 10080篇 |
2018年 | 9420篇 |
2017年 | 8515篇 |
2016年 | 7909篇 |
2015年 | 9657篇 |
2014年 | 14236篇 |
2013年 | 15308篇 |
2012年 | 13976篇 |
2011年 | 16306篇 |
2010年 | 14199篇 |
2009年 | 14055篇 |
2008年 | 12621篇 |
2007年 | 12264篇 |
2006年 | 11098篇 |
2005年 | 9299篇 |
2004年 | 7470篇 |
2003年 | 6561篇 |
2002年 | 5164篇 |
2001年 | 4408篇 |
2000年 | 3653篇 |
1999年 | 3245篇 |
1998年 | 2822篇 |
1997年 | 2537篇 |
1996年 | 2226篇 |
1995年 | 1893篇 |
1994年 | 1641篇 |
1993年 | 1331篇 |
1992年 | 1170篇 |
1991年 | 1030篇 |
1990年 | 826篇 |
1989年 | 700篇 |
1988年 | 593篇 |
1987年 | 533篇 |
1986年 | 538篇 |
1985年 | 1121篇 |
1984年 | 1200篇 |
1983年 | 818篇 |
1982年 | 879篇 |
1981年 | 696篇 |
1980年 | 632篇 |
1979年 | 506篇 |
1978年 | 362篇 |
1977年 | 292篇 |
1976年 | 273篇 |
1975年 | 196篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
971.
The histopathology of papillary thyroid hyperplasia and papillary thyroid carcinoma is similar enough to cause a diagnostic
dilemma in a few cases. Both lesions may have papillary fronds with fibrovascular cores, nuclear crowding, and nuclear anisocytosis.
Formalin-fixed paraffin-embedded tissues from 30 randomly selected patients with papillary thyroid hyperplasia and an equal
number from patients with papillary thyroid carcinoma were analyzed for expression of cytokeratin 19 (CK19), galectin-3, and
HBME-1. Cases of papillary thyroid carcinoma had moderate to strong CK19, galectin-3, and HBME-1 reactivity although both
CK19 and galectin-3 showed positive staining in a significant number of nonneoplastic thyroid cases. HBME-1 was uncommon in
the nonneoplastic cases. These results indicate that HBME-1 may be useful in helping to distinguish papillary thyroid carcinoma
from hyperplasia in diagnostically difficult cases. 相似文献
972.
Montero R Serrano L Dávila V Segura Y Arrieta A Fuentes R Abad I Valencia L Sierra P Camacho R 《Environmental and molecular mutagenesis》2003,42(3):216-222
Micronuclei and other biomarkers were evaluated in oral cells from 11- to 16-year-old girls living in a foster home in the central area of México City. Variables analyzed for possible association with these biomarkers include smoking habits, body mass index, metabolic polymorphisms for NAT1 and GSTM1 and whether the cells were obtained from the cheek or pharynx. The results indicated that individuals having the NAT1*10 homozygous genotype showed a significant increase in chromatin buds and binucleated cells. When the damage in the cheek was compared with damage in the pharynx, a significant increase in micronuclei and binucleated cells was found for the latter tissue in all the individuals analyzed. 相似文献
973.
974.
Many tumor cells are resistant to tumor necrosis factor alpha (TNFalpha)-induced apoptosis. Adenovirus early region 1A (AdE1A) sensitizes the otherwise resistant cells to TNFalpha. AdE1A also stabilizes the p53 protein. The present study demonstrates a correlation between AdE1A-induced sensitization and stabilization of p53 in TNFalpha-induced apoptosis since the N-terminal and CR2 regions, the binding sites for CBP/p300, Rb and 26S proteasome regulatory components, are required for both these actions of AdE1A. TNFalpha does not induce apoptosis and AdE1A fails to sensitize TNFalpha cytotoxicity in p53-negative cells. However, introduction of exogenous p53 overcomes the cellular resistance to TNFalpha toxicity and enhances AdE1A sensitization, demonstrating that AdE1A sensitizes TNFalpha-induced apoptosis by its stabilization of p53. A proteasome inhibitor, lactacystin, enhances TNFalpha cytotoxicity in p53-positive and -negative cells, suggesting that accumulation of cellular proteins other than p53 might also regulate the cellular response to TNFalpha signaling. 相似文献
975.
Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma 总被引:7,自引:0,他引:7
AIB1, a member of the steroid receptor coactivator 1 family, has been cloned on 20q12 and is a candidate oncogene in human breast cancer. It is commonly amplified and overexpressed in several types of human cancers. In this study, we examined the expression of AIB1, as related to clinicopathologic features, in 85 human colorectal cancers (CRCs). The status of the number of AIB1 copies, p53 expression, and DNA ploidy was also analyzed. The overexpression of AIB1 was detected in 35% of CRCs. Amplification of AIB1 was observed in 10% of CRCs. In addition, the overexpression of AIB1 was observed more frequently in CRCs in later clinical stages (T3 N1 M0/T3 N0 2M1), compared with that in T3 N0 M0 stage (P < .05). These results suggest that overexpression of AIB1 might provide a selective advantage for the developmental growth and/or progression of subsets of CRCs. In addition, a significant correlation (P < .05) of overexpression of AIB1 with p53 overexpression as well as with aneuploid DNA content was observed in these CRCs. The overexpression of p53 was also correlated significantly with CRC DNA ploidy (P < .05). Furthermore, there was a substantial population of CRCs showing overexpression of both AIB1 and p53 protein and all had aneuploid DNA content; most of these were in the later clinical stage. These findings suggest a possible convergence of AIB1 with a pathway involving p53, which might induce chromosomal instability and affect the clinical phenotype of a subset of CRCs. 相似文献
976.
Wang C Horiuchi A Imai T Ohira S Itoh K Nikaido T Katsuyama Y Konishi I 《The Journal of pathology》2004,202(2):215-223
BRCA1 is a putative tumour suppressor gene responsible for a hereditary ovarian cancer syndrome. To clarify the possible involvement of BRCA1 in the development of sporadic ovarian neoplasms, this study analysed the immunohistochemical expression of BRCA1 protein in normal ovarian surface epithelium and 119 epithelial ovarian tumours (19 benign, 24 borderline, and 76 malignant tumours). Loss of heterozygosity (LOH) of BRCA1 was examined using three microsatellite markers to analyse the relationship between BRCA1 expression and alterations of the BRCA1 gene. Methylation of the BRCA1 promoter was also analysed by methylation-specific PCR. In ovarian carcinomas showing heterogeneous expression of BRCA1 protein in the same tumour, LOH and methylation status were analysed using microdissection techniques. Finally, the relationship of BRCA1 expression or its genetic alteration to clinicopathological parameters and patient survival was analysed. Ovarian surface epithelial cells expressed BRCA1 protein. Decreased expression of BRCA1 was found in 16% of benign tumours, 38% of borderline tumours, and 72% of carcinomas. LOH of BRCA1 was demonstrated in no benign tumours, 15% of borderline tumours, and 66% of carcinomas. Methylation of BRCA1 was not detected in benign or borderline tumours, but was present in 31% of carcinomas. Reduced expression of BRCA1 correlated with the presence of gene methylation. The frequency of BRCA1 methylation and LOH was higher in serous carcinomas than in other types. In one of the three serous carcinomas that showed heterogeneous expression of BRCA1, BRCA1-positive borderline-like tumour cells were LOH-positive and methylation-negative, whereas adjacent BRCA1-negative carcinoma cells were LOH-positive and methylation-positive. The prognosis of carcinoma patients did not correlate with BRCA1 expression or genetic status. These findings suggest that reduced expression of BRCA1 protein along with genetic and epigenetic changes of the BRCA1 gene play an important role in the development of sporadic ovarian carcinomas, particularly those of serous histology. 相似文献
977.
EpCAM, epithelial membrane antigen (EMA)-mucin 1 (MUC1), mesothelin, and CD9 have been reported to be overexpressed at the RNA level in ovarian carcinomas. By using immunohistochemistry, we profiled the protein expression of these gene products in ovarian carcinoma tissues and compared them with benign ovarian surface epithelium (OSE) and cortical inclusion cysts (CICs). Immunoreactivity for EMA and calretinin were used to define epithelial and mesothelial differentiation in nontumor tissues, respectively. Papillary serous (n = 16) and endometrioid (n = 10) tumors were immunopositive for EMA/MUC1 (100%), mesothelin (75% and 30%, respectively), CD9 (88% and 90%, respectively), and EpCAM (100%). All ovarian carcinomas and carcinoma cell lines tested were negative for calretinin. In nonneoplastic ovary, both OSE and CICs ranged from flat-to-cuboidal to stratified and ciliated in appearance. OSE with a cuboidal morphology had a similar immunoreactivity as omental peritoneum, expressing calretinin, mesothelin, and CD9. In contrast, CICs with stratified and ciliated epithelium show expression patterns similar to those in fallopian tubes. They frequently expressed EMA, EpCAM, mesothelin, and CD9. This immunophenotype is preserved in ovarian carcinomas, suggesting that Müllerian metaplasia signals the acquisition of these markers and that their expression is maintained in ovarian carcinomas that originate from this epithelium. 相似文献
978.
This study analyzed the expression of anti-islet autoantibodies and HLA-DR and -DQ genotypes in Korean children with type 1 diabetes mellitus (T1DM). The positivity of the anti-ICA512, anti-GAD65, and anti-insulin autoantibodies in the newly onset T1DM patients (n = 15) was 66.7%, 86.7%, and 46.7%, respectively, and all of them had one or more of the autoantibodies. HLA analysis showed higher frequencies of HLA-DRB1*0301, *0405, *09012 and -DQB1*0201, *0401, *03032 alleles in T1DM patients compared to controls (P(c) < 0.05). Because HLA-DQB1*0401, *03032 alleles carry aspartic acid at position 57 of DQB, susceptibility to T1DM in Korean children was not related to the presence of aspartic acid at position 57 of DQB1 locus. We suggest this unique HLA-DR, -DQ allele distribution might be an important factor for the low incidence of T1DM in Korea, and the combined anti-islet autoantibody assays could be valuable screening markers for the early detection of T1DM in Korea. 相似文献
979.
本文报告硒对白细胞介素1(IL-1)和白细胞介素2(IL-2)的产生及其反应性的影响。实验结果显示:T淋巴细胞经低浓度亚硒酸钠预处理后,丝裂原诱导的IL-2活性水平显著升高,表明硒可促进IL-2的产生;在亚硒酸钠存在的条件下,T淋巴母细胞对IL-2的应答增强;硒可明显促进巨噬细胞分泌IL-1,并可促进胸腺细胞对IL-1的应答。提示硒可能通过促进IL-1的分泌和应答而间接促进IL-2的产生和应答,进而促进T细胞及其他免疫细胞的增殖和活性,以增强机体免疫功能。 相似文献
980.
Summary We have cloned the Cephalosporium acremonium pyr4 gene by cross-hybridization with the equivalent gene from Neurospora crassa, the closest relative from which this gene is available. The C. acremonium pyr4 gene complements an E. coli pyrF mutant lacking orotidine-5-phosphate decarboxylase (OMPdecase), and most probably does not contain introns. Maxicell analysis in E. coli shows that it encodes a 46 kDa polypeptide. The C. acremonium OMPdecase contains a highly conserved pentadecapeptide characteristic for this category of enzyme. Extensive sequence comparison suggests an important role of this region in enzymatic activity. 相似文献